
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Gypenoside L inhibits hepatocellular carcinoma by targeting the SREBP2-HMGCS1 axis and enhancing immune response
Man‐Yu Xiao, Wenjing Pei, Si Li, et al.
Bioorganic Chemistry (2024) Vol. 150, pp. 107539-107539
Closed Access | Times Cited: 4
Man‐Yu Xiao, Wenjing Pei, Si Li, et al.
Bioorganic Chemistry (2024) Vol. 150, pp. 107539-107539
Closed Access | Times Cited: 4
Showing 4 citing articles:
Natural Saponins on Cholesterol‐Related Diseases: Treatment and Mechanism
Man‐Yu Xiao, Si Li, Wenjing Pei, et al.
Phytotherapy Research (2025)
Closed Access
Man‐Yu Xiao, Si Li, Wenjing Pei, et al.
Phytotherapy Research (2025)
Closed Access
Targeting cholesterol metabolism: a promising therapy strategy for cancer
Chun-Lan Dai, Zhixin Qiu, Anqi Wang, et al.
Acta Pharmacologica Sinica (2025)
Closed Access
Chun-Lan Dai, Zhixin Qiu, Anqi Wang, et al.
Acta Pharmacologica Sinica (2025)
Closed Access
Neuroprotective effects of gypenosides on LPS-induced anxiety and depression-like behaviors
Mei Guo, Wenjing Pei, Liming Liu, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113367-113367
Closed Access | Times Cited: 3
Mei Guo, Wenjing Pei, Liming Liu, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113367-113367
Closed Access | Times Cited: 3
Research Progress on Anti-Tumor Active Components and Mechanisms of Gypenosides
梅玉 刘
Journal of Clinical Personalized Medicine (2024) Vol. 03, Iss. 04, pp. 2262-2269
Open Access
梅玉 刘
Journal of Clinical Personalized Medicine (2024) Vol. 03, Iss. 04, pp. 2262-2269
Open Access